(R)-DOI   Click here for help

GtoPdb Ligand ID: 157

Synonyms: (-)-DOI
Compound class: Synthetic organic
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 1
Hydrogen bond donors 1
Rotatable bonds 4
Topological polar surface area 44.48
Molecular weight 321.02
XLogP 2.66
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COc1cc(I)c(cc1CC(N)C)OC
Isomeric SMILES COc1cc(I)c(cc1C[C@H](N)C)OC
InChI InChI=1S/C11H16INO2/c1-7(13)4-8-5-11(15-3)9(12)6-10(8)14-2/h5-7H,4,13H2,1-3H3/t7-/m1/s1
InChI Key BGMZUEKZENQUJY-SSDOTTSWSA-N
References
1. Fitzgerald LW, Conklin DS, Krause CM, Marshall AP, Patterson JP, Tran DP, Iyer G, Kostich WA, Largent BL, Hartig PR. (1999)
High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: evidence favoring the ternary complex and two-state models of agonist action.
J Neurochem, 72 (5): 2127-34. [PMID:10217294]
2. Knight AR, Misra A, Quirk K, Benwell K, Revell D, Kennett G, Bickerdike M. (2004)
Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
Naunyn Schmiedebergs Arch Pharmacol, 370 (2): 114-23. [PMID:15322733]
3. May JA, Chen HH, Rusinko A, Lynch VM, Sharif NA, McLaughlin MA. (2003)
A novel and selective 5-HT2 receptor agonist with ocular hypotensive activity: (S)-(+)-1-(2-aminopropyl)-8,9-dihydropyrano[3,2-e]indole.
J Med Chem, 46 (19): 4188-95. [PMID:12954071]
4. Nelson DL, Lucaites VL, Wainscott DB, Glennon RA. (1999)
Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, -HT(2B) and 5-HT2C receptors.
Naunyn Schmiedebergs Arch Pharmacol, 359 (1): 1-6. [PMID:9933142]
5. Parker MA, Marona-Lewicka D, Lucaites VL, Nelson DL, Nichols DE. (1998)
A novel (benzodifuranyl)aminoalkane with extremely potent activity at the 5-HT2A receptor.
J Med Chem, 41 (26): 5148-9. [PMID:9857084]